-transparent.png){kind=logo}
The synthesis and the GABAA binding activity of a series of 1-amino-2-alkylphthalazinium bromides (series A) and 1-amino-3-alkylphthalazinium bromides (series B) bearing different substituents at position-4 are reported. Some compounds of series A, bearing a lipophilic substituent at position-4, showed a good binding activity as well as in vivo convulsant activity.
Related Publications
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
November 2002,
Bioorganic & medicinal chemistry letters,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
May 2001,
Journal of medicinal chemistry,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
June 2007,
Bioorganic & medicinal chemistry letters,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
April 2007,
Bioorganic & medicinal chemistry letters,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
October 2015,
Chemical biology & drug design,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
December 2001,
Journal of medicinal chemistry,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
January 2021,
Current computer-aided drug design,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
January 2013,
Bioorganic & medicinal chemistry,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
February 2009,
Bioorganic & medicinal chemistry letters,
D Catarzi, and
L Cecchi, and
G Filacchioni, and
A Bartolini, and
R Carpenedo, and
A Galli, and
F Mori
July 2004,
Bioorganic & medicinal chemistry,
